Case Study: Healthtech Consulting
Investigating Series A Ventures in the German Healthcare Sector
Demonstrated expertise in German healthcare landscape
Performed 90 hours of desk research and market analysis
Conducted 7 in-depth interviews with industry experts
Our client
Our client is the startup incubator arm of a global insurance company focusing on insurtech, healthtech and mobility. Within the health tech industry, its goal is to automate diagnostics, to leverage data to improve care pathways and to create a more individualized healthcare system.
Challenges & Objectives
Our client is the startup incubator arm of a global insurance company focusing on insurtech, healthtech and mobility. Within the health tech industry, its goal is to automate diagnostics, to leverage data to improve care pathways and to create a more individualized healthcare system.
How our service helped
Using a range of German and English resources our desk research produced a report which highlighted the major players in the market and their interplay. Performing interviews with both starts-ups and established companies allowed our GTM analysis to reveal the most recent developments in the German healthcare system.
Result
The client gained an in-depth understanding of the universal multi-player health care system in Germany and the reimbursement by statutory and private health insurance companies. With our help, the client managed to identify the most attractive business models in the German healthtech funding landscape. Furthermore, our GTM analysis allowed the client to understand how insurance companies could reimburse its portfolio companies for their products and services in Germany.
OTHER PROJECTS
A selection of our previous projects:
Medtech-Consulting
Analysis of an OTC drug for the treatment of mouth and throat infections on behalf of a German pharmaceutical company as well as the investigation of market access requirements.
Analysis of marketability
Analysis of an OTC drug for the treatment of mouth and throat infections on behalf of a German pharmaceutical company as well as the investigation of market access requirements.